12-110911176-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 9P and 4B. PVS1PP5BS2
The NM_000432.4(MYL2):c.403-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000549 in 1,456,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000432.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL2 | NM_000432.4 | c.403-1G>A | splice_acceptor_variant, intron_variant | ENST00000228841.15 | NP_000423.2 | |||
MYL2 | NM_001406745.1 | c.361-1G>A | splice_acceptor_variant, intron_variant | NP_001393674.1 | ||||
MYL2 | NM_001406916.1 | c.346-1G>A | splice_acceptor_variant, intron_variant | NP_001393845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL2 | ENST00000228841.15 | c.403-1G>A | splice_acceptor_variant, intron_variant | 1 | NM_000432.4 | ENSP00000228841.8 | ||||
MYL2 | ENST00000548438.1 | c.361-1G>A | splice_acceptor_variant, intron_variant | 3 | ENSP00000447154.1 | |||||
MYL2 | ENST00000663220.1 | c.346-1G>A | splice_acceptor_variant, intron_variant | ENSP00000499568.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 149818Hom.: 0 Cov.: 31 FAILED QC
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248224Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134348
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1456326Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 724420
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 149818Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72892
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 10 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 08, 2023 | This sequence change affects an acceptor splice site in intron 6 of the MYL2 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely disrupts the C-terminus of the protein. This variant is present in population databases (no rsID available, gnomAD 0.0009%). Disruption of this splice site has been observed in individuals with autosomal recessive MYL2-related conditions (PMID: 11748309, 23365102). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2148683). Studies have shown that disruption of this splice site results in activation of a cryptic splice site 23 nucleotides upstream of the original splice site and introduces a new termination codon (PMID: 23365102). However the mRNA is not expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Oct 23, 2023 | This variant causes a G to A nucleotide substitution at the -1 position of intron 6 of the MYL2 gene. Splice site prediction tools suggest that this variant may have a significant impact on RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MYL2-related disorders in the literature. This variant has been identified in 1/248224 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Clinical relevance of loss-of-function MYL2 splice and truncation variants in autosomal dominant cardiovascular disorders is not clearly established. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at